New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

Gabapentin Capsules recalled by Aurobindo Pharma USA

The lot is said to contain come empty capsules.

Aurobindo Pharma USA is voluntarily recalling a lot of their Gabapentin Capsules, because some of them contain some empty capsules, according to the FDA website.

The affected Gabapentin lot is GESB14011-A, Expiration 12/2015 and is packaged in 100-count bottles, NDC 16714-662-01. The product can be identified by the imprint D on yellow cap and 03 on yellow body with black edible ink.

It was distributed through Northstar label to retail outlets nationwide.

New Jersey-based Aurobindo Pharma USA has not received any reports of adverse events related to this recall to date, but has received four complaints for empty capsules.

Gabapentin is used as in the treatment of epilepsy and for the management of postherpetic neuralgia (pain after shingles), and empty capsules could result in missed dose(s) of gabapentin resulting in adverse health consequences that could range from no effect, short term reduction in efficacy, short term withdrawal effect, or status epilepticus (long period seizures) that could be life-threatening.

How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub